Trial Profile
A single-centre retrospective study to evaluate the anakinra in patients with familial mediterranean fever.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2020
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Amyloidosis; Familial Mediterranean fever
- Focus Therapeutic Use
- 09 Dec 2020 Results published in the Rheumatology
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
- 06 Feb 2016 New trial record